Cannabis use disorder (CUD) is an underappreciated risk of using cannabis that affects~
10% of the 193 million cannabis users worldwide. The individual and public health burdens …

The view that substance addiction is a brain disease, although widely accepted in the
neuroscience community, has become subject to acerbic criticism in recent years. These …

Importance No US national data are available on the prevalence and correlates ofDSM-5–
defined major depressive disorder (MDD) or on MDD specifiers as defined inDSM-5 …

Drug consumption is driven by a drug's pharmacological effects, which are experienced as
rewarding, and is influenced by genetic, developmental, and psychosocial factors that …

Alcohol use disorder is a major contributor to the morbidity and mortality burden worldwide.
It often coexists with other psychiatric disorders; however, the nature of this comorbidity is …

Objective To examine psychiatric and somatic correlates of DSM5 eating disorders (EDs)—
anorexia nervosa (AN), bulimia nervosa (BN), and bingeeating disorder (BED)—in a …

This review provides an overview of the changing US epidemiology of cannabis use and
associated problems. Adults and adolescents increasingly view cannabis as harmless, and …

Cannabis is widely used among adolescents and adults. In the US, marijuana laws have
been changing, and Americans increasingly favor legalizing cannabis for medical and …

The diagnosis of mental disorder initially appears relatively straightforward: Patients present
with symptoms or visible signs of illness; health professionals make diagnoses based …

Cannabis has been used for medicinal purposes for thousands of years. The prohibition of
cannabis in the middle of the 20th century has arrested cannabis research. In recent years …